MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by august202013on Oct 31, 2023 10:20am

200 Views

Post# 35709097

Suspicion $700K debtors in 3rd Quarter Fin

MM probably having difficulty to collect that amount and consequently delaying the 31-7-2023 to end November 2023 hopefully to have some resolution.

If suspicion is CORRECT than MM MUST release
The year end financial today without anymore delay and qualifying that legal actions have commenced to recover it. Quite certain Minority LONG TERM shareholders got no choice but to accept it

HC should consider to then hire a CONSULTANT not another scientist to navigate MIR for future innovations and review existing ones.

Otherwise will continue to be same old same old.

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features